62
Participants
Start Date
June 30, 2014
Primary Completion Date
June 30, 2019
Study Completion Date
December 31, 2019
Epoetin Alpha
"Infant study 1: VLBW infant study subjects (weighing 1.0 to 1.5 kg at birth) who are otherwise receiving standard clinical care will be treated with Epoetin Alpha according to a dosing algorithm.~Infant study 2:~Dosing algorithm will be determined by results of Infant Study 1."
Biotinylated Red Blood Cells
Biotinylated red blood cells will be transfused to infants to determine red blood cell lifespan.
University of Iowa Hospitals and Clinics, Iowa City
Department of Health and Human Services
FED
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Janssen Scientific Affairs, LLC
INDUSTRY
John A Widness
OTHER